FMP
Akouos, Inc.
AKUS
NASDAQ
Inactive Equity
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
13.29 USD
0 (0%)
About
ceo
Dr. Emmanuel Simons M.B.A., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.akouos.comexchange
NASDAQ
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
CIK
0001722271
ISIN
US00973J1016
CUSIP
00973J101
Address
645 Summer Street
Phone
857 410 1818
Country
US
Employee
103
IPO Date
Jun 26, 2020
Key Executives
Name
Title
Pay
Year Born
Dr. Luk H. Vandenberghe M.D., Ph.D.
Founder & Member of Scientific Advisory ...
0
N/A
Dr. Emmanuel Simons M.B.A., Ph.D.
Co- Founder, Pres, Chief Executive Offic...
790.72k
1983
Mr. William F. Sewell Ph.D.
Founder & Member of Scientific Advisory ...
0
N/A
Mr. Richard Smith M.D.
Founder & Member of Scientific Advisory ...
0
N/A
Ms. Sachiyo Minegishi
Chief Financial Officer, Treasurer, Assi...
0
1978
Dr. Michael John McKenna M.D.
Co-Founder, Chief Medical Officer & Memb...
539.35k
1957
Dr. Karoline K. Shair
Senior Vice President, Gen. Counsel, Chi...
0
N/A
Dr. Aaron Tward M.D., Ph.D.
Chief Scientific Officer
0
N/A
Ms. Stacy Price
Chief Technical Officer
0
N/A
Ms. Jennifer Anne Wellman M.S.
Chief Operating Officer
568.67k
1978
As of December 31, 2024, the total employee count stands at 103, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
